CN Bio
CN Bio is a close-knit team of passionate scientists, engineers and creative thinkers, all working together towards a shared goal – a future where drugs are discovered more quickly, brought to patients more cost-effectively and with less animal experimentation. Day to day, their cohesive team design, manufacture, promote and support organ-on-a-chip solutions that enable their customers to do something incredible – recreate three-dimensional human organs and tissues in the laboratory to improve understanding of human physiology, disease and the effectiveness of new drugs.
Latest Content
    CN Bio Launches PhysioMimix DILI Assay Kit: Human 24, for Enhanced Preclinical Toxicology Testing
    CN Bio Signs Strategic Partnership With Primetech Corporation To Establish Distribution Channel for OOC Solutions in Japan
    CN Bio Launches PhysioMimix Bioavailability Assay Kit: Human 18
    A Reflection on Global Fatty Liver Day 2024: How Organ-on-a-Chip Addresses R&D Challenges
    CN Bio and Altis Biosystems Partner To Develop Next-Generation Human Gut/Liver In Vitro Model
    CN Bio PhysioMimix Organ-on-a-Chip Data Supports Inipharm’s INI-822 for Metabolic Liver Disease Treatment
    CN Bio and LifeNet Health LifeSciences Partner To Supply Validated Primary Human Cells for Microphysiological Systems
    CN Bio Extends Microphysiological System Portfolio
    The FDA Expands Collaboration With CN Bio To Evaluate Multi-Organ Microphysiological System